Kontakt 2021, 23(2):120-125 | DOI: 10.32725/kont.2021.020

Specific prescription medications as drivers of out-of-pocket payments and cost-related medication non-adherence in the Czech RepublicSocial Sciences in Health - Original article

Veronika Kočiš Krůtilová*, Dominika Doubková
Mendel University in Brno, Faculty of Business and Economics, Brno, Czech Republic

Objective: Out-of-pocket payments for medications take a substantial part of Czech households' expenditure for health, which could have a negative impact on medication adherence. Therefore, the objective of this study is to explore the impact of prescription medications related to specific health conditions on patients' out-of-pocket payments and cost-related medication non-adherence.

Methods: We used the data from the second wave of the European Health Interview Survey. Running the analyses in hierarchical stages, our main interest was the influence of medications related to 21 health conditions. A conventional regression method with robust standard errors was used for the investigation of out-of-pocket payments for prescription medication. Predictors of cost-related medication non-adherence were identified using a logistic regression model.

Results: We found that medications for stroke, asthma, myocardial infarction, chronic lung disease, chronic kidney disease, and diabetes contribute to high co-payments. Moreover, cost sharing for stroke, asthma and myocardial infarction medications might have serious implications for desirable consumption as they are associated with medication non-adherence.

Conclusions: We conclude that prescription practices and reimbursement policies in relation to medications for stroke, asthma and myocardial infarction should be carefully explored and physicians should be motivated to prescribe medications covered fully or with low co-payments.

Keywords: Czech Republic; Health condition; Medication non-adherence; Out-of-pocket payment; Prescription medication

Received: December 2, 2020; Revised: March 11, 2021; Accepted: April 22, 2021; Prepublished online: April 27, 2021; Published: May 5, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kočiš Krůtilová V, Doubková D. Specific prescription medications as drivers of out-of-pocket payments and cost-related medication non-adherence in the Czech Republic. Kontakt. 2021;23(2):120-125. doi: 10.32725/kont.2021.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    Attachments

    Download fileAppendix_B.pdf

    File size: 66.31 kB

    Download fileAppendix_A.pdf

    File size: 70.87 kB

    References

    1. Alexa J, Rečka L, Votápková J, van Ginneken E, Spranger A, Wittenbecher F (2015). Czech Republic: Health system review. Health Systems in Transition 17(1): 1-165.
    2. Andersen R, Newman JF (2005). Societal and individual determinants of medical care utilisation in the United States. Milbank Quarterly 83(4): 1-28. DOI: 10.1111/j.1468-0009.2005.00428.x. Go to original source...
    3. Costa-Font J, Kanavos P, Rovira J (2007). Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia. Applied Economics 39(5): 541-551. DOI: 10.1080/00036840500438947. Go to original source...
    4. Czech Statistical Office (2020). Household Consumption Expenditures - 2018. [online] [cit. 2020-01-23]. Available at: https://www.czso.cz/csu/czso/household-consumption-expenditures-2018
    5. Eurostat (2013). European Health Interview Survey (EHIS wave 2) - methodological manual. Luxembourg: Publications Office of the European Union, 193 p. DOI: 10.2785/43280. Go to original source...
    6. Eurostat (2019). RAMON - Reference and Management of Nomenclatures. [online] [cit. 2019-11-22]. Available at: https://ec.europa.eu/eurostat/ramon/miscellaneous/index.cfm?TargetUrl=DSP_DEGURBA
    7. Gemmill MC, Thomson S, Mossialos E (2008). What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health 7: 12. DOI: 10.1186/1475-9276-7-12. Go to original source... Go to PubMed...
    8. Grossman M (1972). On the Concept of Health Capital and the Demand for Health. J Politic Econ 80(2): 223-255. DOI: 10.1086/259880. Go to original source...
    9. Hennessy D, Sanmartin C, Ronksley P, Weaver R, Campbell D, Manns B, et al. (2016). Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. Health Rep 27(6): 3-8.
    10. Łuczak J, García-Gómez P (2012). Financial burden of drug expenditures in Poland. Health Policy 105(2-3): 256-264. DOI: 10.1016/j.healthpol.2012.01.004. Go to original source... Go to PubMed...
    11. McLeod L, Bereza G, Shim M, Grootendorst P (2011). Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data. Open Med 5(1): e1-e9. Go to PubMed...
    12. Morgan SG, Lee A (2017). Cost-related non-adherence to prescribed medicines among older adults: A cross-sectional analysis of a survey in 11 developed countries. BMJ Open 7(1): e014287. DOI: 10.1136/bmjopen-2016-014287. Go to original source... Go to PubMed...
    13. Piette JD, Heisler M, Horne R, Caleb Alexander GC (2006). A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med 62(4): 846-857. DOI: 10.1016/j.socscimed.2005.06.045. Go to original source... Go to PubMed...
    14. Sanwald A, Theurl E (2017). Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey. Eur J Health Econ 18(4): 435-447. DOI: 10.1007/s10198-016-0797-y. Go to original source... Go to PubMed...
    15. Sinnott S-J, Buckley C, O'Riordan D, Bradley C, Whelton H (2013). The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-Analysis. PLoS One 8(5): e64914. DOI: 10.1371/journal.pone.0064914. Go to original source... Go to PubMed...
    16. State Institute for Drug Control (2018). Regulation of prices and reimbursements for pharmaceuticals. [online] [cit. 2020-01-23]. Available at: http://www.sukl.eu/medicines/regulation-of-prices-and-reimbursements-for-pharmaceuticals
    17. State Institute for Drug Control (2020). List of reimbursed medicinal products. [online] [cit. 2020-01-23]. Available at: http://www.sukl.eu/sukl/list-of-reimbursed-medicinal-products
    18. UZIS CR (2018). European Health Interview Survey (EHIS 2014). [online] [cit. 2019-01-30]. Available at: https://ehis.uzis.cz/index-en.php?pg=ehis-2014
    19. Vogler S, Österle A, Mayer S (2015). Inequalities in medicine use in Central Eastern Europe: An empirical investigation of socioeconomic determinants in eight countries. Int J Equity Health 14: 124. DOI: 10.1186/s12939-015-0261-0. Go to original source... Go to PubMed...
    20. VZP CR (2020). Ročenka za rok 2018 [Annual Book 2018]. [online] [cit. 2020-01-29]. Available at: https://media.vzpstatic.cz/media/Default/rocenky/rocenka_vzp_2018.pdf

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content